Open AccessBasal serum cortisol and adrenocorticotropic hormone levels in patients with atopic dermatitis
Author(s) -
Zohreh Tehranchinia,
Hoda Rahimi,
Sara Lofti
Publication year - 2017
Publication title -
dermatology practical and conceptual
Language(s) - English
Resource type - Journals
ISSN - 2160-9381
DOI - 10.5826/dpc.0704a07
Subject(s) - adrenocorticotropic hormone , medicine , basal (medicine) , atopic dermatitis , immunoglobulin e , scorad , endocrinology , hormone , disease , immunology , antibody , dermatology life quality index , insulin
Certain studies suggest that percutaneous absorption of topical steroids may cause suppression of hypothalamic-pituitary-adrenal axis (HPAA) in atopic dermatitis (AD) patients. This study aimed to investigate the basal serum cortisol, adrenocorticotropic hormone (ACTH), and IgE levels in patients with AD and their correlation with the disease severity.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom